ICC Melanoma

Translate the description into English (United States) using Google Translate?Translate the description back to Italian (Italy)

COME GESTIRE LA TOSSICITÀ E VALUTARE LA RISPOSTA ALL’IMMUNOTERAPIA NEI PAZIENTI CON MELANOMA

La terapia immunologica del melanoma sta attraversando una fase di grande evoluzione, grazie agli importanti risultati ottenuti in molti studi clinici, a partire dal 2010, a seguito dell’introduzione degli anticorpi diretti contro i checkpoint immunologici come CTLA-4 e, in particolare, PD-1. Lo scopo di questo progetto è di approfondire i principali scenari di difficile gestione del paziente affetto da melanoma in terapia con anticorpi ant-PD-1, attraverso esempi di situazioni cliniche interattive.
HOW TO MANAGE THE TOXICITY AND ASSESSING THE RESPONSE IN PATIENTS WITH melanoma immunotherapy

The melanoma immunotherapy is going through a phase of great development, thanks to the important achievements in many clinical trials, starting in 2010, following the introduction of antibodies to immunological checkpoint as CTLA-4, and, in particular, PD -1. The purpose of this project is to deepen the main scenarios of melanoma difficult patient management affection for antibody therapy ant-PD-1, through examples of interactive clinical situations.
Read more
Collapse
Loading...

What's New

Corretto bug su autenticazione utente
Read more
Collapse

Additional Information

Updated
March 13, 2019
Size
11M
Installs
10+
Current Version
1.1.3
Requires Android
4.1 and up
Content Rating
Everyone
Permissions
Offered By
Forum Service s.r.l.
Developer
Via Martin Piaggio 17/6 16122 Genova GE
©2020 GoogleSite Terms of ServicePrivacyDevelopersArtistsAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.